Related references
Note: Only part of the references are listed.Metformin and cancer: new applications for an old drug
Taxiarchis V. Kourelis et al.
MEDICAL ONCOLOGY (2012)
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
X. -X. He et al.
ANNALS OF ONCOLOGY (2011)
Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)
Daniele Campa et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
LKB1/AMPK/mTOR signaling pathway in hematological malignancies From metabolism to cancer cell biology
Alexa S. Green et al.
CELL CYCLE (2011)
The LKB1 complex-AMPK pathway: the tree that hides the forest
Michael Sebbagh et al.
FAMILIAL CANCER (2011)
Metformin: Its emerging role in oncology
Dragan Micic et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2011)
Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling
Russell A. Miller et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
2-Deoxy-D-Glucose Treatment of Endothelial Cells Induces Autophagy by Reactive Oxygen Species-Mediated Activation of the AMP-Activated Protein Kinase
Qilong Wang et al.
PLOS ONE (2011)
Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
Ramandeep Rattan et al.
NEOPLASIA (2011)
Metformin: A Therapeutic Opportunity in Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2010)
Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles
So-Jung Park et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
AMPK and the biochemistry of exercise: implications for human health and disease
Erik A. Richter et al.
BIOCHEMICAL JOURNAL (2009)
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Bei B. Zhang et al.
CELL METABOLISM (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Mechanism of interaction between human serum albumin and N-alkyl phenothiazines studied using spectroscopic methods
P. B. Kandagal et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin - Response to Farooki and Schneider
Samantha L. Bowker et al.
DIABETES CARE (2006)
Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells
A Woods et al.
CELL METABOLISM (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking
M Schapira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Mechanism by which metformin reduces glucose production in type 2 diabetes
RS Hundal et al.
DIABETES (2000)
Rational discovery of novel nuclear hormone receptor antagonists
M Schapira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
